De Rijk Md, Launer L, Berger K, Breteler M, Dartigues J, Baldereschi M, et al. Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 Suppl 5):S21-3.
Dorsey ER, Constantinescu R, Thompson J, Biglan K, Holloway R, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384–6.
Article CAS PubMed Google Scholar
Sveinbjornsdottir S. The clinical symptoms of Parkinson’s disease. J Neurochem. 2016;139:318–24.
Article CAS PubMed Google Scholar
Gerlach OH, Winogrodzka A, Weber WE. Clinical problems in the hospitalized Parkinson’s disease patient: systematic review. Mov Disord. 2011;26(2):197–208.
Article PubMed PubMed Central Google Scholar
Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010;25(6):704–9.
Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson’s disease and are we missing them? Mov Disord. 2010;25(15):2493–500.
Alderwick H, Dixon J. The NHS long term plan. BMJ. 2019;364:l84. https://doi.org/10.1136/bmj.l84.
Newman S, Steed L, Mulligan K. Self-management interventions for chronic illness. Lancet. 2004;364(9444):1523–37.
Richardson J, Loyola-Sanchez A, Sinclair S, Harris J, Letts L, MacIntyre NJ, et al. Self-management interventions for chronic disease: a systematic scoping review. Clin Rehabil. 2014;28(11):1067–77.
Parkinsons UK. Available from: https://www.parkinsons.org.uk/information-and-support.
Fereshtehnejad S-M. Strategies to maintain quality of life among people with Parkinson’s disease: what works? Neurodegenerative Dis Manag. 2016;6(5):399–415.
Pigott JS, Kane EJ, Ambler G, Walters K, Schrag A. Systematic review and meta-analysis of clinical effectiveness of self-management interventions in Parkinson’s disease. BMC Geriatr. 2022;22(1):1–29.
Tuijt R, Tan A, Armstrong M, Pigott J, Read J, Davies N, et al. Self-management components as experienced by people with Parkinson’s disease and their carers: a systematic review and synthesis of the qualitative literature. Parkinson’s Dis. 2020;2020:8857385.
Armstrong M, Tuijt R, Read J, Pigott J, Davies N, Manthorpe J, et al. Health care professionals’ perspectives on self-management for people with Parkinson’s: qualitative findings from a UK study. BMC Geriatr. 2021;21(1):1–11.
Pearce G, Parke HL, Pinnock H, Epiphaniou E, Bourne CL, Sheikh A, et al. The PRISMS taxonomy of self-management support: derivation of a novel taxonomy and initial testing of its utility. J Health Serv Res Policy. 2016;21(2):73–82.
Corbin JM, Strauss A. Unending work and care: managing chronic illness at home. 1st edition. U.S: Jossey-Bass Inc.; 1988. p 384.
Michie S, Van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):1–12.
Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;2013(346):e7586.
Reichmann H. Clinical criteria for the diagnosis of Parkinson’s disease. Neurodegener Dis. 2010;7(5):284–90.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.
Pigott J, Kane EJ, Ambler G, Walters K, Schrag A. Systematic review and meta-analysis of clinical effectiveness of self-management interventions in Parkinson’s. 2021.
Shah R, Read J, Davies N, Nimmons D, Pigott J, Schrag A, et al. People with Parkinson’s perspectives and experiences of self-management: qualitative findings from a UK study. PLoS One. 2022;17(9):e0273428.
Article CAS PubMed PubMed Central Google Scholar
Farr JN, Jenkins JJ, Paterson DG. Simplification of flesch reading ease formula. J Appl Psychol. 1951;35(5):333.
Rogers G, Davies D, Pink J, Cooper P. Parkinson’s disease: summary of updated NICE guidance. BMJ. 2017;358:j1951.
Walters K, Frost R, Kharicha K, Avgerinou C, Gardner B, Ricciardi F, et al. Home-based health promotion for older people with mild frailty: the HomeHealth intervention development and feasibility RCT. Health Technol Assess (Winchester, England). 2017;21(73):1.
Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures. J Neurol. 1998;245(1):S10–4.
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.
Martinez-Martin P, Schrag A, Weintraub D, Rizos A, Rodriguez-Blazquez C, Chaudhuri KR, et al. Pilot study of the international Parkinson and movement disorder society-sponsored non-motor rating scale (MDS-NMS). Mov Disord Clin Pract. 2019;6(3):227–34.
Article PubMed PubMed Central Google Scholar
Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2001;4(6):256–62.
Gureje O, Obikoya B. The GHQ-12 as a screening tool in a primary care setting. Soc Psychiatry Psychiatr Epidemiol. 1990;25(5):276–80.
Article CAS PubMed Google Scholar
Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(41p):1005–26.
Article PubMed PubMed Central Google Scholar
Hoefman R, Van Exel N, Brouwer W. iMTA valuation of informal care questionnaire. 2015.
McCrone P. Capturing the costs of end-of-life care: Comparisons of multiple sclerosis, Parkinson’s disease, and dementia. J Pain Symptom Manage. 2009;38(1):62–7.
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.
Article CAS PubMed PubMed Central Google Scholar
Flynn TN, Chan P, Coast J, Peters TJ. Assessing quality of life among British older people using the ICEPOP CAPability (ICECAP-O) measure. Appl Health Econ Health Policy. 2011;9(5):317–29.
Yap P. Validity and reliability of the Zarit Burden Interview in assessing caregiving burden. Ann Acad Med Singapore. 2010;39:758–63.
Pillas M, Selai C, Quinn NP, Lees A, Litvan I, Lang A, et al. Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers). Qual Life Res. 2016;25(1):81–8.
Horváth K, Aschermann Z, Kovács M, Makkos A, Harmat M, Janszky J, et al. Changes in quality of life in Parkinson’s disease: how large must they be to be relevant? Neuroepidemiology. 2017;48(1–2):1–8.
Peto V, Jenkinson C, Fitzpatrick R. Determining minimally important differences for the PDQ-39 Parkinson’s disease questionnaire. Age Ageing. 2001;30(4):299–302.
Article CAS PubMed Google Scholar
Jenkinson C, Fitzpatrick R, Peto V, Dummett S, Morley D, Saunders P. The Parkinson’s disease questionnaire. Health Services Research Unit Oxford: Joshua Horgan Print Partnership. 1998. Available from: https://innovation.ox.ac.uk/wp-conontent/uploads/2014/09/PDQ_Manual_ExecSummary_and_Contents-1-orign1.pdf.
Horváth K, Aschermann Z, Ács P, Deli G, Janszky J, Komoly S, et al. Minimal clinically important difference on the Motor Examination part of MDS-UPDRS. Parkinsonism Relat Disord. 2015;21(12):1421–6.
Hunter RM, Baio G, Butt T, Morris S, Round J, Freemantle N. An educational review of the statistical issues in analysing utility data for cost-utility analysis. Pharmacoeconomics. 2015;33(4):355–66.
Coast J, Flynn TN, Natarajan L, Sproston K, Lewis J, Louviere JJ, et al. Valuing the ICECAP capability index for older people. Soc Sci Med. 2008;67(5):874–82.
Jones KC, Weatherly H, Birch S, Castelli A, Chalkley M, Dargan A, et al. Unit Costs of Health and Social Care 2022 Manual. 2022.
NHS England, Improvement National Cost Collection 2019. NHS England and NHS Improvement. 2020. https://www.england.nhs.uk/wp-content.
JF Committee. British National formulary (online). London: BMJ group and pharmaceutical press; 2016.
Hunter R, Proctor G, Noyce A, Schrag A, Ward E, Galloway J. Research into biomarkers to facilitate the early identification of Parkinson’s disease: a decision analytic model to determine the feasibility and value. Trials. 2013;14(1):1.
Comments (0)